Wildlife Pharmaceuticals
Wildlife Pharmaceuticals is a South African GMP-accredited manufacturer that develops, registers, and distributes scheduled opioid-based immobilization medicines, antidotes, and Pneu-Dart delivery hardware for wildlife veterinarians, researchers, and conservation professionals worldwide. Now a subsidiary of Fagron.
- Company typePrivate
- Founded1997
- HeadquartersJohannesburg, South Africa
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What Wildlife Pharmaceuticals does
Wildlife Pharmaceuticals (Pty) Ltd is a South African specialty pharmaceutical manufacturer founded in 1997 by Dr. Cobus Raath that develops, registers, and distributes controlled medicines for the chemical immobilization of wild and exotic animals. The company is headquartered in White River, South Africa, where it operates an integrated cGMP facility housing active pharmaceutical ingredient (API) manufacturing, robotic sterile filling, and a SAHPRA-licensed pharmacy. Its product portfolio centers on Schedule 4, 5, and 6 opioid agonists and antagonists — including Captivon 98 (etorphine), Thianil (thiafentanil), Activon (diprenorphine), Trexonil (naltrexone), Zoosedin 20 (atipamezole), Sedolam 50 (midazolam), and Butadyne 50 (butorphanol) — paired with Pneu-Dart delivery hardware (X-Caliber and Model 389 projectors, Type C/P/U darts, and telemetry darts with up to 2.4 km tracking range) for remote drug administration.
The company's revenue model combines one-time sales of restricted scheduled pharmaceuticals and Pneu-Dart hardware to authenticated veterinary and medical professionals with fee-for-service offerings: cGMP contract API manufacturing, robotic sterile filling, and regulatory affairs services including dossier compilation, Section 21 applications, and medicine registration support. Products are registered in South Africa and the United Arab Emirates, and since 2023 Wildlife Pharmaceuticals has operated as a subsidiary of the international pharmaceutical group Fagron, which provides global distribution reach.
Wildlife Pharmaceuticals serves three primary customer personas — wildlife veterinarians, wildlife researchers, and conservation professionals — across EMEA, the Middle East, and additional global markets. Go-to-market is sales-led, supported by a webinar series, hosted wildlife immobilization courses, peer-reviewed publications, and academic sponsorships that reinforce the company's scientific credibility and domain authority in wildlife anaesthesia.
Wildlife Pharmaceuticals firmographics
Firmographics- Name
- Wildlife Pharmaceuticals
- Legal name
- Wildlife Pharmaceuticals (Pty) Ltd
- Website
- https://wildpharm.co.za
- Company type
- Private
- Founded year
- 1997
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Wildlife Pharmaceuticals is a South African GMP-accredited manufacturer that develops, registers, and distributes scheduled opioid-based immobilization medicines, antidotes, and Pneu-Dart delivery hardware for wildlife veterinarians, researchers, and conservation professionals worldwide. Now a subsidiary of Fagron.
- Ownership category
- akta.pro rank
Wildlife Pharmaceuticals industry classification
Industry- Product category
- Veterinary Pharmaceuticals
- NAICS
- Pharmaceutical Preparation Manufacturing (325412)
- SIC
- Pharmaceutical Preparations (2834)
- akta.pro primary industry
- Pain Management, Anesthesia & Critical Care Drugs (HLAMAEAF)
- akta.pro secondary industry
- Veterinary Pharmacy, Vaccine & Biologics Services (AFAEANAK)
Keywords
Where Wildlife Pharmaceuticals is headquartered
LocationHeadquarters
- HQ city
- Johannesburg
- HQ country
- South Africa
- HQ region
- Africa
Offices1 record
Markets served
Wildlife Pharmaceuticals business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Operations, Personnel, Technology or R&D, Infrastructure, Marketing or Sales
Revenue model
- Pharmaceutical Products: Sale of specialized wildlife veterinary medicines including chemical immobilization drugs, sedatives, tranquilisers, and antidotes under Schedule 4, 5, and 6 classifications. Products registered with South African regulatory authority.
- Pneu-Dart Products: Distribution of Pneu-Dart delivery equipment including projectors, darts, and telemetry darts for precise drug delivery to wildlife.
- API Manufacturing Services: Contract manufacturing of Active Pharmaceutical Ingredients for veterinary medicine manufacturers, focusing on quality and industry standards compliance.
- Sterile Filling Services: cGMP-compliant sterile filling manufacturing services using advanced robotic systems for pharmaceutical products.
- Regulatory Services: Regulatory affairs support including acting as applicant for medicine registrations, dossier compilation and submission, and product lifecycle management for sterile veterinary parenteral products. Section 21 applications and importation of unregistered products.
Go-to-market motion1 record
Distribution channels3 records
Marketing channels6 records
Wildlife Pharmaceuticals product offering
Product offeringCore offering
Wildlife Pharmaceuticals manufactures and distributes a specialized range of scheduled veterinary medicines for the chemical immobilization of wild and exotic animals, including opioid agonists (Thianil, Captivon 98), antagonists/ reversal agents (Trexonil, Activon, Zoosedin 20), sedatives (Sedolam 50, Butadyne 50), and antidotes. The company complements these pharmaceuticals with Pneu-Dart delivery equipment (dart projectors, Type C/P/U darts, and telemetry darts) for remote drug administration. Additionally, the company offers cGMP-compliant API manufacturing, sterile filling services, and veterinary pharmacy/regulatory services to veterinary medicine manufacturers and professionals worldwide.
Product overview
Wildlife Pharmaceuticals is a specialized pharmaceutical company offering a comprehensive portfolio of wildlife veterinary medicines focused on chemical immobilization solutions. Their core product line includes opioid agonists and antagonists: CAPTIVON 98 (etorphine), THIANIL (thiafentanil), ACTIVON (diprenorphine), TREXONIL (naltrexone), ZOOSEDIN 20 (atipamezole), SEDOLAM 50 (midazolam), and Butadyne 50 (butorphanol) for sedating, immobilizing, and reversing effects in wild animals. They complement their pharmaceutical offerings with specialized Pneu-Dart delivery devices including the X-Caliber Projector, Model 389 Projector, and various dart types (Type C, Type P, Type U) for remote drug delivery, plus telemetry darts for animal tracking. Their services include API manufacturing, sterile filling (cGMP), and veterinary pharmacy services with global medicine distribution. Founded in 1997 and now part of the Fagron family, they serve wildlife veterinarians worldwide from their South African operations.
Differentiator
Problem solved
Functional benefit
Products and services
- Thianil S6 scheduled opioid (thiafentanil oxalate 10 mg/ml) used for chemical immobilization of wildlife animals; one of the company's flagship products registered with SAHPRA.
- Captivon 98 S6 scheduled opioid agonist (etorphine HCl 9.8 mg/ml) for reversible narcosis with analgesia in wildlife animals, used for chemical immobilization of wild species.
- Trexonil S4 scheduled opioid antagonist (naltrexone HCl 50 mg/ml) used to reverse opioid effects in wildlife animals; one of the company's flagship products.
- Activon S4 scheduled opioid antagonist (diprenorphine HCl 12 mg/ml) used to reverse the effects of etorphine and other opioids in wildlife animals.
- Zoosedin 20 S4 scheduled alpha-2 adrenergic antagonist (atipamezole HCl 20 mg/ml) used to reverse sedation and anesthesia in wildlife animals.
- Sedolam 50 S5 scheduled benzodiazepine (midazolam HCl 50 mg/ml) used for sedation, anxiolysis, and muscle relaxation in wildlife veterinary procedures.
- Butadyne 50 Butorphanol tartrate product used as an analgesic and sedative in wildlife veterinary medicine for chemical immobilization protocols.
- X-Caliber Projector Gas-based dart projector featuring rotating power control mechanism behind urethane-coated forearm, machined aluminum construction, virtually silent operation, and the greatest RDD ranges in the Pneu-Dart lineup, designed for precise drug delivery to wildlife.
- Model 389 Projector Professional dart rifle with hinged breech-loading barrel and pioneering Airflow Control Ports (ACP) technology eliminating tail-kick, featuring 5-position power control mechanism, 13mm caliber rifled barrel, and range up to 65m with Type C or Type U darts.
- Pneu-Dart Type C, P, and U Darts Disposable darts available in sizes 0.5cc to 5cc with 14-gauge or 13-gauge cannulas. Type C for standard delivery, Type P designed for CO2 Air projectors and Blo-Jector with optional gelatin collar and wire barb customization, and Type U universal tail darts compatible with both Pneu-Dart and non-Pneu-Dart projectors.
- Pneu-Dart Telemetry Darts Transmitter darts equipped with microprocessor control and solid-state components for tracking darted animals, offering up to 2.4 kilometers effective tracking range and up to 12 continuous hours of transmission battery life; includes the 414 PLL Transmitter Kit.
- API Manufacturing Services Active Pharmaceutical Ingredient (API) manufacturing services for veterinary medicine manufacturers, including the development of new API synthetic pathways with focus on quality and adherence to industry standards.
- Sterile Filling Services cGMP-compliant sterile filling services for pharmaceutical products using innovative approaches and advanced robotic systems.
- Veterinary Pharmacy and Regulatory Services Licensed pharmacy services approved by SAHPRA including medicine registration applications, dossier compilation and submission, product lifecycle management, importation of unregistered products (Section 21 applications), and local/international distribution of scheduled veterinary medicines.
Companies that use Wildlife Pharmaceuticals
Customer profileNamed customers3 records
Segments3 records
Ideal customer profiles3 records
Wildlife Pharmaceuticals technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature7 records
Wildlife Pharmaceuticals partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- FagroncoreWildlife Pharmaceuticals expanded its global footprint by joining the international Fagron family in 2023. This strategic partnership provides Wildlife Pharmaceuticals with access to Fagron's global distribution network and resources while maintaining its specialized focus on wildlife veterinary medicine.
Scale indicators3 records
Recent moves6 records
Expansion highlights5 records
Wildlife Pharmaceuticals competitors and assessment
Company assessmentBroad incumbents
- Zoetis: Global leader in animal health pharmaceuticals and biologics, with a wide portfolio including sedatives, anesthetics, and reversal agents used in veterinary practice. Competes indirectly with Wildlife Pharmaceuticals across the broader veterinary pharma category and represents the dominant incumbent in the space.
- Vetoquinol: French specialty animal health pharmaceutical group with a portfolio that includes sedation, anesthesia, and pain management products. Comparable to Wildlife Pharmaceuticals in being a focused veterinary pharma operator with international registrations, though serving a broader species base.
- Dechra Pharmaceuticals: UK-headquartered specialty veterinary pharmaceutical company offering a broad portfolio of licensed veterinary medicines including anesthetics and analgesics. While not wildlife-focused, it is a key incumbent in veterinary pharmaceuticals and a natural acquirer/partner profile comparable in operating model.
- Elanco Animal Health: Large diversified animal health company offering pharmaceuticals across companion animal, livestock, and specialty segments. Relevant incumbent comparator for veterinary pharmaceutical manufacturing scale, regulatory footprint, and global distribution capability.
Regional players
- Norbrook Laboratories: Northern Ireland-headquartered veterinary pharmaceutical manufacturer with strong presence in EMEA and emerging markets, producing a range of sterile injectable veterinary products. Comparable in cGMP sterile injectable manufacturing focus and regulated-product distribution footprint, though with broader species coverage than Wildlife Pharmaceuticals.
Direct peers
- Dan-Inject: Danish manufacturer of dart projectors and consumables for wildlife and livestock remote delivery. Competes with Pneu-Dart in the same delivery-device category and serves overlapping wildlife veterinarian customers targeted by Wildlife Pharmaceuticals.
- ZooPharm: U.S. wildlife and exotic animal pharmacy that compounds and distributes immobilization agents and reversal drugs to zoological and wildlife professionals. Closest U.S. analog to Wildlife Pharmaceuticals' pharmacy and scheduled-drug distribution model for the wildlife vet market.
- Pneu-Dart: U.S.-based manufacturer of remote drug delivery systems (dart projectors, darts, telemetry darts) used in wildlife capture and livestock handling. Wildlife Pharmaceuticals distributes Pneu-Dart products globally and the two serve the same wildlife veterinarian customers with complementary pharmaceutical and device solutions.
Emerging players
- Wildlife Vets International: UK-based charity supporting wildlife veterinary capacity building, training, and clinical guidance globally. Closely aligned mission and customer base with Wildlife Pharmaceuticals, and a relevant peer for training/course delivery and thought-leadership dynamics in wildlife medicine.
- Fauna Research Inc. Wildlife capture and veterinary consulting firm with deep wildlife chemical immobilization expertise and long history with white-tailed deer and other North American species. Comparable to Wildlife Pharmaceuticals in field-led immobilization expertise though primarily a service rather than product company.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks5 records
Key highlights6 records
Customer concentration
Wildlife Pharmaceuticals social profiles
Digital presenceWildlife Pharmaceuticals compliance and trust
Trust signalCompliance1 record
Wildlife Pharmaceuticals financial estimates
Financial estimateRevenue estimate
Valuation estimate
Wildlife Pharmaceuticals leadership team
Management profileNumber of profiles
Profiles1 record
Wildlife Pharmaceuticals funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Wildlife Pharmaceuticals M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Wildlife Pharmaceuticals
What does Wildlife Pharmaceuticals do?
Wildlife Pharmaceuticals manufactures and distributes a specialized range of scheduled veterinary medicines for the chemical immobilization of wild and exotic animals, including opioid agonists (Thianil, Captivon 98), antagonists/ reversal agents (Trexonil, Activon, Zoosedin 20), sedatives (Sedolam 50, Butadyne 50), and antidotes. The company complements these pharmaceuticals with Pneu-Dart delivery equipment (dart projectors, Type C/P/U darts, and telemetry darts) for remote drug administration. Additionally, the company offers cGMP-compliant API manufacturing, sterile filling services, and veterinary pharmacy/regulatory services to veterinary medicine manufacturers and professionals worldwide.
Is Wildlife Pharmaceuticals a public or private company?
Wildlife Pharmaceuticals is a private company. It is classified as corporate owned and is currently operating.
When was Wildlife Pharmaceuticals founded?
Wildlife Pharmaceuticals was founded in 1997. It employs 11 to 50 people.
Where is Wildlife Pharmaceuticals based?
Wildlife Pharmaceuticals is headquartered in Johannesburg, South Africa, in the Africa region.
How does Wildlife Pharmaceuticals make money?
Five revenue lines are on record. Pharmaceutical Products are the primary driver. The others are pneu-Dart Products, API Manufacturing Services, sterile Filling Services and regulatory Services.
Who are Wildlife Pharmaceuticals's main competitors?
Broad incumbents on record are Zoetis, Vetoquinol, Dechra Pharmaceuticals and Elanco Animal Health. Norbrook Laboratories is listed as a regional player. Direct peers are Dan-Inject, ZooPharm and Pneu-Dart. Emerging players are Wildlife Vets International and Fauna Research Inc..
Does Wildlife Pharmaceuticals have an API?
No public API is recorded for Wildlife Pharmaceuticals.
What industry is Wildlife Pharmaceuticals in?
Wildlife Pharmaceuticals's product category is Veterinary Pharmaceuticals. Its primary akta.pro industry code is HLAMAEAF, Pain Management, Anesthesia & Critical Care Drugs, with a secondary code of AFAEANAK, Veterinary Pharmacy, Vaccine & Biologics Services. Its NAICS code is 325412 and its SIC code is 2834.